Get startedLog in
    Picture of Cohance Lifesciences logo

    COHANCE — Cohance Lifesciences News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Suven Pharmaceuticals Ltd Dec Quarter Consol Net Profit Rises

    Picture of Cohance Lifesciences logoCohance Lifesciences
    10/02/2021 08:04
    Feb 10 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * SUVEN PHARMACEUTICALS LTD - DECLARED AN INTERIM DIVIDEND
OF 1
RUPEE PER SHARE
    * SUVEN PHARMACEUTICALS LTD DEC QUARTER CONSOL NET PROFIT
1.14
BILLION  RUPEES VERSUS 579.1 MILLION RUPEES YEAR AGO
    * SUVEN PHARMACEUTICALS LTD  DEC QUARTER  CONSOL REVENUE
FROM
OPERATIONS 2.75 BILLION RUPEES VERSUS 1.79 BILLION RUPEES YEAR
AGO

Source text for Eikon:  ID:nBSE7WTMhS 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cohance Lifesciences

    See all news